BiVictriX Therapeutics (BVX) Stock Chart & Stock Price History Add Compare Share Share Chart Stock AnalysisChartInsider Trades BiVictriX Therapeutics Stock Price Performance 5 Day Performance-100.00%1 Month Performance-100.00%3 Month Performance-100.00%6 Month Performance-100.00%Year-To-Date PerformanceN/A1 Year Performance-100.00% Receive BVX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich. BVX Stock Chart for Sunday, December, 22, 2024 BVX Chart by TradingView BiVictriX Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/19/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/18/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/17/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/16/2024N/AGBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/13/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million Get the Latest News and Ratings for BVX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/11/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/10/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/09/2024N/AGBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/06/2024N/AGBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/04/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/03/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million12/02/2024N/AGBX 10GBX 10GBX 8.631.54 million shs£8.25 million11/29/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million11/28/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million11/27/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million11/26/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million11/25/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million11/22/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million11/21/2024GBX 10GBX 10GBX 10GBX 8.631.54 million shs£8.25 million Related Companies Sareum Stock Chart Arecor Therapeutics Stock Chart Ondine Biomedical Stock Chart OptiBiotix Health Stock Chart NetScientific Stock Chart Oncimmune Stock Chart Synairgen Stock Chart Aptamer Group Stock Chart Cizzle Biotechnology Stock Chart Fusion Antibodies Stock Chart Receive BVX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BVX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiVictriX Therapeutics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share BiVictriX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
